Is Electrocardiogram Helpful in Predicting a Rise in Troponin I as a Marker of Anthracycline Cardiotoxicity?

Objective:Screening patients on anthracycline-based chemotherapy regimens for the development of cardiotoxicity can be resource intensive. We therefore studied various traditional electrocardiogram (ECG) parameters to correlate and possibly predict the development of elevated Troponin I as a surroga...

Full description

Bibliographic Details
Published in:	European Journal of Breast Health
Main Authors:	Kader Muneer, Benny Jose, Gajendra Dubey, Ajayakumar T, Sajeev CG, Krishnan MN
Format:	Article
Language:	English
Published:	Galenos Publishing House 2022-10-01
Subjects:	anthracyclines cardiotoxic agents chemotherapy ecg troponin i
Online Access:	http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/s-electrocardiogram-helpful-in-predicting-a-rise-i/53088

Similar Items

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
by: S. Slavcheva
Published: (2024-05-01)

Cardiotoxicity in Children With Acute Ieukemia Treated by Anthracycline; Detected by Cardiac Troponins and Echcocardiography
by: Yaran Abbas Abdulqader, et al.
Published: (2023-04-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

High-sensitivity troponin I as a predictor of left ventricular dysfunction in the use of cardiotoxic anticancer agents for breast cancer in patients with predominantly low and moderate risk of cardiotoxicity
by: V. D. Levina, et al.
Published: (2022-12-01)

Early detection of anthracycline‐ and trastuzumab‐induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters
by: Belén Díaz‐Antón, et al.
Published: (2022-04-01)

Anthracycline-induced cardiotoxicity: mechanisms, monitoring, and prevention
by: Yun Qiu, et al.
Published: (2023-12-01)

Assessment of anthracycline-induced long-term cardiotoxicity in patients with hematological malignancies
by: Aws Sabah Al-Rubaye, et al.
Published: (2019-01-01)

CHEMOTHERAPY CARDIOTOXICITY SCREENING WITH CARDIAC TROPONINS
by: O. V. Krikunova, et al.
Published: (2015-12-01)

Electrocardiographic and biochemical analysis of anthracycline induced cardiotoxicity in breast cancer patients from Southern Sri Lanka
by: Jayasinghe Arachchige Nirosha Sandamali, et al.
Published: (2023-03-01)

Genetic basis of anthracyclines cardiotoxicity: Literature review
by: M. Yu. Sinitsky, et al.
Published: (2021-10-01)

Racial and Ethnic Disparities in Cardiotoxicity in Patients With Cancer Treated With Anthracyclines
by: Lili Zhang, et al.
Published: (2025-04-01)

An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
by: Sicong Xie, et al.
Published: (2024-06-01)

Challenges in the implementation of cardio-oncology trials: lessons learnt from investigating statins in the prevention of anthracycline cardiotoxicity
by: John Lee, et al.
Published: (2024-12-01)

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances
by: Hongyun Mao, et al.
Published: (2025-08-01)

Correction: An update of the molecular mechanisms underlying anthracycline induced cardiotoxicity
by: Sicong Xie, et al.
Published: (2025-09-01)

Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity
by: Fibi Meshrkey, et al.
Published: (2025-09-01)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
by: Parisa Firoozbakhsh, et al.
Published: (2024-05-01)

Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
by: Lars Michel, et al.
Published: (2020-04-01)

Lifestyle and Pharmacological Interventions to Prevent Anthracycline-Related Cardiotoxicity in Cancer Patients
by: Luigi Spadafora, et al.
Published: (2025-06-01)

Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysis
by: Matthew Dean, et al.
Published: (2023-04-01)

Exploring Anthracycline-Induced Cardiotoxicity from the Perspective of Protein Quality Control
by: Shanshan Li, et al.
Published: (2024-06-01)

Tissue Doppler Imaging for anthracycline cardiotoxicity monitoring in pediatric patients with cancer
by: Francesco Venturelli, et al.
Published: (2018-09-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
by: Becky Meiners, et al.
Published: (2018-08-01)

Incidence and risk factors of anthracycline-induced cardiotoxicity in long-term survivors of pediatric cancer: A population based cohort study
by: Prathana Nathan, et al.
Published: (2022-12-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
by: Leila Mabudian, et al.
Published: (2022-09-01)

Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
by: Andia Taghdiri
Published: (2024-06-01)

Effect of shenmai injection on anthracycline-induced cardiotoxicity: A systematic review and meta-analysis
by: Lili Yang, et al.
Published: (2024-08-01)

Prevention and treatment of anthracycline-induced cardiotoxicity: A bibliometric analysis of the years 2000–2023
by: Yifan Kong, et al.
Published: (2024-05-01)

Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
by: Xi Zhou, et al.
Published: (2023-10-01)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
by: Alexandros Briasoulis, et al.
Published: (2022-02-01)

Pediatric Cardio-Oncology: Screening, Risk Stratification, and Prevention of Cardiotoxicity Associated with Anthracyclines
by: Xiaomeng Liu, et al.
Published: (2024-07-01)

Value of Left Ventricular Global Longitudinal Strain Assessed by Two-Dimensional Strain Imaging in Early Detection of Anthracycline Mediated Cardiotoxicity
by: Yasser Abdel-Hady, et al.
Published: (2022-04-01)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

A retrospective analysis of the association of obesity with anthracycline- and trastuzumab-induced cardiotoxicity in the treatment of breast cancer and lymphoma
by: Mallorie L. Huff, et al.
Published: (2024-07-01)

Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis
by: Xiaoyu Liu, et al.
Published: (2025-09-01)

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019-04-01)

Prevention and management of anthracycline induced cardiotoxicity: A review
by: Ian Osoro, et al.
Published: (2022-12-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)